Design Therapeutics
DSGN
DSGN
63 hedge funds and large institutions have $614M invested in Design Therapeutics in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
21% less capital invested
Capital invested by funds: $773M → $614M (-$159M)
Holders
63
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$15.1M | |
| 2 | +$9.47M | |
| 3 | +$3.66M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$3.53M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$2.93M |
Top Sellers
| 1 | -$6.02M | |
| 2 | -$4.58M | |
| 3 | -$3.45M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$879K |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$346K |